trending Market Intelligence /marketintelligence/en/news-insights/trending/dRdzwOJuGd1uL--_2Ktp3w2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Sanofi launches digitally enabled manufacturing site in Massachusetts

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform

Sanofi launches digitally enabled manufacturing site in Massachusetts

Paris-based Sanofi established its first digital manufacturing facility for biologics production in Framingham, Mass.

The new facility will manufacture biologics for Sanofi's specialty care segment, the French drugmaker said in an Oct. 15 news release.

The production facility is part of Sanofi's move to focus on biologics-based therapies as the company transforms its research and development pipeline.

Sanofi aims to increase levels of productivity, agility and flexibility using the manufacturing site's advanced technologies, the company added.

The company plans to expand its digital transformation initiative in its facilities in Toronto, as well as in Suzano, Brazil; Waterford, Ireland; Sisteron, France; and Geel, Belgium.